Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: ITC 5/2/13 Response/submission by Barnes & Nobles to Order 35-AL

Good questions for those with ITC discovery rules experience and/or knowledge. I hope that TPL is producing more evidence because they can and not because they are in need of defending their position.

Share
New Message
Please login to post a reply